Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077

被引：37

作者：

Landovitz, Raphael J. ^{[1
,2
]}

Zangeneh, Sahar Z. ^{[3
]}

Chau, Gordon ^{[3
]}

Grinsztejn, Beatriz ^{[4
]}

Eron, Joseph J. ^{[5
]}

Dawood, Halima ^{[6
]}

Magnus, Manya ^{[7
]}

Liu, Albert Y. ^{[8
]}

Panchia, Ravindre ^{[9
]}

Hosseinipour, Mina C. ^{[10
]}

Kofron, Ryan ^{[1
,2
]}

Margolis, David A. ^{[11
]}

Rinehart, Alex ^{[11
]}

Adeyeye, Adeola ^{[12
]}

Burns, David ^{[12
]}

McCauley, Marybeth ^{[13
]}

Cohen, Myron S. ^{[5
]}

Currier, Judith S. ^{[1
,2
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Ctr AIDS Res & Educ, Dept Med,Div Infect Dis, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Ctr HIV Prevent, Los Angeles, CA 90095 USA

[3] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA

[4] Fundacao Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas INI, Lab HIV, Rio De Janeiro, Brazil

[5] Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USA

[6] Univ KwaZulu Natal, Dept Med, Durban, South Africa

[7] George Washington Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Milken Inst, Washington, DC USA

[8] San Francisco Dept Publ Hlth, Populat Hlth Div, Bridge HIV, San Francisco, CA USA

[9] Univ Witwatersrand, Perinatal HIV Res Unit, Chris Hani Baragwanath Acad Hosp, Soweto, South Africa

[10] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC 27515 USA

[11] ViiV Healthcare, Res Triangle Pk, Durham, NC USA

[12] NIAID, Div AIDS, NIH, Rockville, MD USA

[13] FHI 360, Sci Facilitat Dept, FHI 360, Washington, DC USA

来源：

CLINICAL INFECTIOUS DISEASES | 2020年 / 70卷 / 02期

基金：

美国国家卫生研究院;

关键词：

cabotegravir; CAB; weight gain; HIV uninfected; DOLUTEGRAVIR; THERAPY; ADULTS;

D O I：

10.1093/cid/ciz439

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Studies in human immunodeficiency virus (HIV)-infected individuals suggest excess weight gain with integrase inhibitor-based antiretroviral therapy. The HIV Prevention Trials Network Study 077 evaluated changes in weight and fasting metabolic parameters in HIV-uninfected individuals randomized to cabotegravir or a placebo. No differences between arms were found for change in weight or fasting metabolic parameters overall or for subgroups.

引用

页码：319 / 322

页数：4

共 50 条

[21] Congenital Anomalies and In Utero Antiretroviral Exposure in Human Immunodeficiency Virus-Exposed Uninfected Infants
Williams, Paige L.
Crain, Marilyn J.
Yildirim, Cenk
Hazra, Rohan
Van Dyke, Russell B.
Rich, Kenneth
Read, Jennifer S.
Stuard, Emma
Rathore, Mobeen
Mendez, Hermann A.
Watts, D. Heather
JAMA PEDIATRICS, 2015, 169 (01) : 48 - 55
[22] Long-term weight gain after initiating combination antiretroviral therapy in treatment-naive Asian people living with human immunodeficiency virus
Ando, Naokatsu
Nishijima, Takeshi
Mizushima, Daisuke
Inaba, Yosuke
Kawasaki, Yohei
Kikuchi, Yoshimi
Oka, Shinichi
Gatanaga, Hiroyuki
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 110 : 21 - 28
[23] Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals
Herrin, Melissa
Tate, Janet P.
Akgun, Kathleen M.
Butt, Adeel A.
Crothers, Kristina
Freiberg, Matthew S.
Gibert, Cynthia L.
Leaf, David A.
Rimland, David
Rodriguez-Barradas, Maria C.
Ruser, Chris B.
Herold, Kevan C.
Justice, Amy C.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (02) : 228 - 236
[24] The Current Status in Terms of Vaccination for Individuals Infected with Human Immunodeficiency Virus
Xu, Nan
Shen, Yanru
Huang, Weijin
Nie, Jianhui
VIRUSES-BASEL, 2025, 17 (02):
[25] Drug Exposure of Long-Acting Cabotegravir and Rilpivirine in Older People With Human Immunodeficiency Virus: A Pharmacokinetic Modeling Study
Bettonte, Sara
Berton, Mattia
Stader, Felix
Battegay, Manuel
Marzolini, Catia
OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (04):
[26] Implementation of Injectable Cabotegravir/Rilpivirine for Treatment of Human Immunodeficiency Virus in Patients With Substance Use Disorders at a Syringe Exchange Clinic
Perez, Amanda
Nieves, Shane
Meisner, Jessica
OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (11):
[27] An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with human immunodeficiency virus
Chow, Wing
Donga, Prina
Cote-Sergent, Aurelie
Rossi, Carmine
Lefebvre, Patrick
Lafeuille, Marie-Helene
Emond, Bruno
Hardy, Helene
CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (08) : 1313 - 1323
[28] Weight Gain and Lipid Profile Changes in Koreans with Human Immunodeficiency Virus undergoing Integrase Strand Transfer Inhibitor-Based Regimens
Kim, Jin
Nam, Hyun-Ju
Jung, Yu-Jin
Lee, Hye-Jung
Kim, Seong-Eun
Kang, Seung-Ji
Park, Kyung-Hwa
Chang, Hyun-Ha
Kim, Shin-Woo
Chung, Eun-Kyung
Kim, Uh Jin
Jung, Sook In
INFECTION AND CHEMOTHERAPY, 2022, 54 (03) : 419 - 432
[29] Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals
Naggie, Susanna
Patel, Keyur
Yang, Lan-Yan
Chow, Shein-Chung
Johnson, Victoria
Guyton, John R.
Muir, Andrew J.
Sulkowski, Mark
Hicks, Charles
OPEN FORUM INFECTIOUS DISEASES, 2015, 2 (02):
[30] Small weight gain is not associated with development of insulin resistance in healthy, physically active individuals
Ohannesian, JP
Marco, CC
Najm, PS
Goldstein, BJ
Caro, JF
Kolaczynski, JW
HORMONE AND METABOLIC RESEARCH, 1999, 31 (05) : 323 - 325

← 1 2 3 4 5 →